Literature DB >> 1648124

Ubiquitin in motor neuron disease: study at the light and electron microscope.

D Schiffer1, L Autilio-Gambetti, A Chiò, P Gambetti, M T Giordana, F Gullotta, A Migheli, M C Vigliani.   

Abstract

Several neurodegenerative diseases, including motor neuron disease (MND), are characterized by formation of abnormal cytoskeleton-derived inclusions which contain ubiquitin (Ubq). We have studied the distribution of Ubq in 26 cases of MND with light and electron microscopic immunocytochemistry. Ubiquitin-positive inclusions were found in neurons of anterior horns in most cases of amyotrophic lateral sclerosis (ALS) but were not present in other forms of MND. Ubiquitin immunoreactivity was observed in 10-15 nm intraneuronal filaments, which were not stained by antibodies to neurofilaments, and on dense bodies of dystrophic neurites throughout the neuropil of anterior horns and pyramidal tracts. Data analysis showed a trend toward lower percentage of Ubq-positive neurons in cases with longer duration of illness or lower number of neurons. A high percentage of Ubq-positive inclusions occurred in cases with an aggressive clinical course, suggesting that ubiquitination takes place at early stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648124     DOI: 10.1097/00005072-199107000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

1.  Basophilic inclusions in sporadic juvenile amyotrophic lateral sclerosis: an immunocytochemical and ultrastructural study.

Authors:  S Matsumoto; H Kusaka; N Murakami; Y Hashizume; H Okazaki; A Hirano
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Ubiquitin-immunoreactive inclusions in anterior horn cells and hypoglossal neurons in a case with Joseph's disease.

Authors:  T Suenaga; H Matsushima; S Nakamura; I Akiguchi; J Kimura
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis.

Authors:  D Troost; P A Sillevis Smitt; J M de Jong; D F Swaab
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Motor neuron disease with pallido-luysio-nigral atrophy.

Authors:  M Bergmann; K Kuchelmeister; A Migheli; D Schiffer; F Gullotta
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Immunocytochemical and ultrastructural studies of the motor cortex in amyotrophic lateral sclerosis.

Authors:  S Sasaki; S Maruyama
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis.

Authors:  S M Chou; H S Wang; A Taniguchi; R Bucala
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

7.  Comparative study of spinal cord ubiquitin expression in post-poliomyelitis and sporadic amyotrophic lateral sclerosis.

Authors:  H Ito; A Hirano
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles.

Authors:  R W Orrell; A W King; D A Hilton; M J Campbell; R J Lane; J S de Belleroche
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

9.  Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators.

Authors:  T Mizutani; S Sakamaki; N Tsuchiya; S Kamei; H Kohzu; R Horiuchi; M Ida; R Shiozawa; T Takasu
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Expression and cellular distribution of ubiquitin in response to injury in the developing spinal cord of Monodelphis domestica.

Authors:  Natassya M Noor; Kjeld Møllgård; Benjamin J Wheaton; David L Steer; Jessie S Truettner; Katarzyna M Dziegielewska; W Dalton Dietrich; A Ian Smith; Norman R Saunders
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.